Cambridge AI Vaccine Against Coronaviruses Succeeds in Phase I Trial, Phase II Planned
Researchers at the University of Cambridge have successfully concluded a Phase I clinical trial for an AI-designed, pan-coronavirus vaccine. The candidate demonstrated an acceptable safety profile and induced broad-spectrum immune ... Read More